Literature DB >> 24771937

S3-Guideline on Diagnostics, Therapy and Follow-up of Malignant Ovarian Tumours: Short version 1.0 - AWMF registration number: 032/035OL, June 2013.

U Wagner1, P Harter1, F Hilpert1, S Mahner1, A Reuß1, A du Bois1, E Petru1, W Meier1, P Ortner1, K König1, K Lindel1, D Grab1, P Piso1, O Ortmann1, I Runnebaum1, J Pfisterer1, D Lüftner1, N Frickhofen1, F Grünwald1, B O Maier1, J Diebold1, S Hauptmann1, F Kommoss1, G Emons1, B Radeleff1, M Gebhardt1, N Arnold1, G Calaminus1, I Weisse1, J Weis1, J Sehouli1, D Fink1, A Burges1, A Hasenburg1, C Eggert1.   

Abstract

Entities:  

Year:  2013        PMID： 24771937      PMCID： PMC3859160          DOI： 10.1055/s-0033-1350713

Source DB:  PubMed          Journal:  Geburtshilfe Frauenheilkd        ISSN： 0016-5751            Impact factor:   2.915


× No keyword cloud information.
  229 in total

1.  A qualitative study of the information needs of high-risk women undergoing prophylactic oophorectomy.

Authors:  N Hallowell
Journal:  Psychooncology       Date:  2000 Nov-Dec       Impact factor: 3.894

2.  Cystectomy for immature teratoma of the ovary.

Authors:  Mario E Beiner; Walter H Gotlieb; Yaacov Korach; Alon Shrim; David Stockheim; Yaacov Segal; Eduard Fridman; Gilad Ben-Baruch
Journal:  Gynecol Oncol       Date:  2004-05       Impact factor: 5.482

Review 3.  Fertility preservation options for women with malignancies.

Authors:  Enbal Marhhom; Ilan Cohen
Journal:  Obstet Gynecol Surv       Date:  2007-01       Impact factor: 2.347

4.  Causes of postoperative mortality after surgery for ovarian cancer.

Authors:  C G Gerestein; R A M Damhuis; M de Vries; A Reedijk; C W Burger; G S Kooi
Journal:  Eur J Cancer       Date:  2009-07-15       Impact factor: 9.162

5.  Recurrent epithelial ovarian carcinoma: a randomized phase III study of pegylated liposomal doxorubicin versus topotecan.

Authors:  A N Gordon; J T Fleagle; D Guthrie; D E Parkin; M E Gore; A J Lacave
Journal:  J Clin Oncol       Date:  2001-07-15       Impact factor: 44.544

6.  Risk-reducing salpingo-oophorectomy in women with a BRCA1 or BRCA2 mutation.

Authors:  Noah D Kauff; Jaya M Satagopan; Mark E Robson; Lauren Scheuer; Martee Hensley; Clifford A Hudis; Nathan A Ellis; Jeff Boyd; Patrick I Borgen; Richard R Barakat; Larry Norton; Mercedes Castiel; Khedoudja Nafa; Kenneth Offit
Journal:  N Engl J Med       Date:  2002-05-20       Impact factor: 91.245

7.  A new prognostic model for FIGO stage 1 epithelial ovarian cancer.

Authors:  Andreas Obermair; Arlan Fuller; Elisa Lopez-Varela; Toon van Gorp; Ignace Vergote; Lynne Eaton; Jeff Fowler; Michael Quinn; Ian Hammond; Donald Marsden; Anthony Proietto; Jonathan Carter; Margaret Davy; Lee Tripcony; Nadeem Abu-Rustum
Journal:  Gynecol Oncol       Date:  2006-11-07       Impact factor: 5.482

8.  Sensitivity and specificity of multimodal and ultrasound screening for ovarian cancer, and stage distribution of detected cancers: results of the prevalence screen of the UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS).

Authors:  Usha Menon; Aleksandra Gentry-Maharaj; Rachel Hallett; Andy Ryan; Matthew Burnell; Aarti Sharma; Sara Lewis; Susan Davies; Susan Philpott; Alberto Lopes; Keith Godfrey; David Oram; Jonathan Herod; Karin Williamson; Mourad W Seif; Ian Scott; Tim Mould; Robert Woolas; John Murdoch; Stephen Dobbs; Nazar N Amso; Simon Leeson; Derek Cruickshank; Alistair McGuire; Stuart Campbell; Lesley Fallowfield; Naveena Singh; Anne Dawnay; Steven J Skates; Mahesh Parmar; Ian Jacobs
Journal:  Lancet Oncol       Date:  2009-03-11       Impact factor: 41.316

9.  Surgery of borderline tumors of the ovary: retrospective comparison of short-term outcome after laparoscopy or laparotomy.

Authors:  Elin Ødegaard; Anne Cathrine Staff; Anton Langebrekke; Vibeke Engh; Mathias Onsrud
Journal:  Acta Obstet Gynecol Scand       Date:  2007       Impact factor: 3.636

10.  Staging laparotomy in early ovarian cancer.

Authors:  R C Young; D G Decker; J T Wharton; M S Piver; W F Sindelar; B K Edwards; J P Smith
Journal:  JAMA       Date:  1983-12-09       Impact factor: 56.272
View more
  16 in total

1.  Incidental (Prophylactic) Salpingectomy at Benign Gynecologic Surgery and Cesarean Section: a Survey of Practice in Austria.

Authors:  F L Potz; G Tomasch; S Polterauer; R Laky; C Marth; K Tamussino
Journal:  Geburtshilfe Frauenheilkd       Date:  2016-12       Impact factor: 2.915

2.  DGGG Guidelines Programme: Status Quo - Quo Vadis!

Authors:  M W Beckmann; I Linde; C Bütof; R Kreienberg; P Gass
Journal:  Geburtshilfe Frauenheilkd       Date:  2014-03       Impact factor: 2.915

3.  Statement of the AGO Kommission Ovar, AGO Study Group, NOGGO, AGO Austria and AGO Switzerland Regarding the Use of Hyperthermic Intraperitoneal Chemotherapy (HIPEC) in Ovarian Cancer.

Authors:  P Harter; A du Bois; S Mahner; J Pfisterer; O Ortmann; C Marth; D Fink; F Hilpert; U Wagner; J Sehouli
Journal:  Geburtshilfe Frauenheilkd       Date:  2016-02       Impact factor: 2.915

4.  Isolated subcutaneous implantation of a borderline ovarian tumor: A case report and review of the literature.

Authors:  Malgorzata Banys-Paluchowski; Borsu Yeganeh; Jutta Luettges; Achim Maibach; Ruediger Langenberg; Natalia Krawczyk; Peter Paluchowski; Holger Maul; Gerhard Gebauer
Journal:  World J Clin Oncol       Date:  2016-04-10

5.  Quality Assurance for Patients with Breast Cancer - the Impact of Clinical Cancer Registries.

Authors:  E C Inwald; M Klinkhammer-Schalke; M Koller; O Ortmann
Journal:  Geburtshilfe Frauenheilkd       Date:  2014-09       Impact factor: 2.915

Review 6.  The Clinical Relevance of Beta Blockers in Ovarian Carcinoma: A Systematic Review.

Authors:  J Hefner; H Csef
Journal:  Geburtshilfe Frauenheilkd       Date:  2016-10       Impact factor: 2.915

7.  Malignant tumors in autoimmune encephalitis with anti-NMDA receptor antibodies.

Authors:  Chloé Bost; Eve Chanson; Géraldine Picard; David Meyronet; Marie-Eve Mayeur; François Ducray; Veronique Rogemond; Dimitri Psimaras; Jean-Christophe Antoine; Jean-Yves Delattre; Virginie Desestret; Jerome Honnorat
Journal:  J Neurol       Date:  2018-07-12       Impact factor: 4.849

8.  Surgical staging and prognosis in serous borderline ovarian tumours (BOT): a subanalysis of the AGO ROBOT study.

Authors:  F Trillsch; S Mahner; E Vettorazzi; L Woelber; A Reuss; K Baumann; M-D Keyver-Paik; U Canzler; K Wollschlaeger; D Forner; J Pfisterer; W Schroeder; K Muenstedt; B Richter; C Fotopoulou; B Schmalfeldt; A Burges; N Ewald-Riegler; N de Gregorio; F Hilpert; T Fehm; W Meier; P Hillemanns; L Hanker; A Hasenburg; H-G Strauss; M Hellriegel; P Wimberger; S Kommoss; F Kommoss; S Hauptmann; A du Bois
Journal:  Br J Cancer       Date:  2015-01-06       Impact factor: 7.640

9.  E-Cadherin fragments as potential mediators for peritoneal metastasis in advanced epithelial ovarian cancer.

Authors:  Fabian Trillsch; Sascha Kuerti; Christine Eulenburg; Eike Burandt; Linn Woelber; Katharina Prieske; Kathrin Eylmann; Leticia Oliveira-Ferrer; Karin Milde-Langosch; Sven Mahner
Journal:  Br J Cancer       Date:  2016-01-19       Impact factor: 7.640

10.  Diagnostic and prognostic potential of serum miR-7, miR-16, miR-25, miR-93, miR-182, miR-376a and miR-429 in ovarian cancer patients.

Authors:  Xiaodan Meng; Simon A Joosse; Volkmar Müller; Fabian Trillsch; Karin Milde-Langosch; Sven Mahner; Maria Geffken; Klaus Pantel; Heidi Schwarzenbach
Journal:  Br J Cancer       Date:  2015-09-22       Impact factor: 7.640
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.